A man fighting for his life got a second chance, but just as he readied himself to settle into his renewed life, he received a terrible call.
Watermelon could help prevent heart attack – Times of India
Watermelon could help prevent heart attackTimes of IndiaA new US study has found a daily slice of watermelon could help prevent heart disease by halting the build-up of harmful cholesterol and also be a help in weight control. Scientists who carried ou…
NY driver license law to boost organ donation – San Francisco Chronicle
NY driver license law to boost organ donationSan Francisco ChronicleALBANY, N.Y. (AP) — New Yorkers getting a new driver's license will have to make a choice about whether to be an organ donor, a measure meant to boost sign-ups. A bill signed int…
Man claims he got cancer from liver transplant
A Cook County man is suing Rush University Medical Center for medical malpractice, alleging he received a liver with malignant cancer tissue during a transplant in May of 2011. Johnny Sirbu, who claims he now has cancer as a result of the transplant, i…
Lonza et Teva examinent la voie à suivre pour l'homologation du Rituximab – Romandie.com
Lonza et Teva examinent la voie à suivre pour l'homologation du RituximabRomandie.comBâle (awp) – Lonza veut clarifier la situation actuelle du développement de son produit "Rituximab" en raison de rumeurs et d'articles de presse p…
Biobusiness Briefs: Trial watch: Dual-acting combination meets heart failure … – Nature.com
Nature.comBiobusiness Briefs: Trial watch: Dual-acting combination meets heart failure …Nature.comNovartis has announced positive results from the Phase II PARAMOUNT trial of its first-in-class angiotensin receptor neprilysin inhibitor combination, L…
Transplant recipients and lymphoma patients far likelier to develop melanoma
Melanoma is on the rise nationally, and transplant recipients and lymphoma patients are far likelier than the average person to get that form of skin cancer and to die from it, a Mayo Clinic review has found.
InterMune's Esbriet receives Health Canada approval for treatment of fatal … – pharmabiz.com
InterMune's Esbriet receives Health Canada approval for treatment of fatal …pharmabiz.comIPF is a progressive and uniformly fatal disease that affects approximately 5,000 to 8,000 Canadians, is characterized by scarring of lung tissue, and has a …
LONZA GROUP AG : Clarification on Biosimilar Activities – 4-traders
LONZA GROUP AG : Clarification on Biosimilar Activities4-tradersBasel, 05 October 2012 – Following several reports and rumors in the past few days in relation to the Biosimilar activities of the joint venture of Lonza and Teva, Lonza wants to clarify t…
Pacemaker could help more heart failure patients – HealthCanal.com
Pacemaker could help more heart failure patientsHealthCanal.comA new study from Karolinska Institutet demonstrates that a change in the ECG wave called the QRS prolongation is associated with a higher rate of heart-failure mortality. According to the t…